Winners Groß

„Win a SICRIT Source“ – Win­ners

We would like to thank all of you for par­ti­ci­pa­ting and sha­ring your vi­si­ons for the SICRIT source and the po­ten­ti­al it holds for your en­dea­vors. Your trust in us has fil­led us with im­mense pri­de, which made sel­ec­ting the top th­ree pro­jects a chal­len­ging task, but here they are:

1) Pro­fes­sor Ré­gis Gouge­on, Uni­ver­si­té de Bour­go­gne, Di­jon, France

Régis Gougeon 2

Our preli­mi­na­ry in­ves­ti­ga­ti­on of wine vo­la­ti­le com­po­si­ti­on, using the SICRIT source, show­ed the re­mar­kab­le abili­ty to di­rect­ly reve­al spe­ci­fic fin­ger­prints from Cham­pa­gne wi­nes. Our ob­jec­ti­ve is now to ex­pand this know­ledge about wine vo­la­ti­le com­po­si­ti­on in rou­ti­ne and into the li­quid pha­se, though the di­rect com­pa­ri­son of LC-ESI-MS2 with LC-SICRIT-MS2. This ap­proach will lead to an un­pre­ce­den­ted mole­cu­lar le­vel eva­lua­ti­on of the im­pact of va­rious eno­lo­gi­cal prac­ti­ces on the wine com­po­si­ti­on and pro­per­ties, in­clu­ding for in­s­tance their oxi­da­tive sta­bi­li­ty. In com­bi­na­ti­on with clas­si­cal ana­ly­ses, new vo­la­ti­le mar­kers will be iden­ti­fied, that will deepen our me­ta­bo­lo­mics da­ta­ba­ses, and ser­ve as tool for stra­ti­fi­ca­ti­on of wi­nes.

2) As­so­cia­te Pro­fes­sor Han­ne Rø­berg-Lar­sen, Uni­ver­si­ty of Oslo, Nor­way

In­ves­ti­ga­ting the im­pact of oxys­te­rols on or­ga­no­ids ex­po­sed to PFAS, fo­cu­sing on en­do­cri­ne-dis­rupt­ing he­alth ef­fects. Li­ver or­ga­no­ids are uti­li­zed for re­se­ar­ching PFAS ef­fects on the li­ver con­cer­ning non-al­co­ho­lic fat­ty li­ver di­se­a­se (NAFLD).

Hanne Røberg Lar­sen

3) Gobi Labs, Co­lo­ra­do, USA

Gobi Labs Kopie

Ana­ly­zing pe­sti­ci­de re­si­dues in can­na­bis pro­ducts and pro­ving SICRIT as ro­bust ana­ly­sis me­thod in a pro­duc­tion dri­ven en­vi­ron­ment. Test­ing SICRIT’s ana­ly­ti­cal ca­pa­bi­li­ties re­gar­ding pro­blem ana­lytes, such as Ab­amec­tin.

We are ex­ci­ted about the­se th­ree pro­jects and eager­ly an­ti­ci­pa­te their out­co­mes. Th­roug­hout the 12-month tri­al pe­ri­od, we will be wri­ting about them and kee­ping you in­for­med.

Stay con­nec­ted with us by fol­lo­wing our up­dates on Lin­ke­dIn or sub­scrib­ing to our news­let­ter!